Why Is Ulcerative Colitis-Focused Landos Biopharma Stock Trading Higher On Monday?
benzinga.com
Monday, AbbVie Inc ABBV agreed to acquire Landos Biopharma Inc LABP for $20.42 per share, or approximately $137.5 million in the aggregate, plus one contingent value right…